Cangrelor (Kengreal)

Indications

Coronary Artery Disease (CAD) (see Coronary Artery Disease, [[Coronary Artery Disease]])

Non-ST Elevation Myocardial Infarction (NSTEMI)
Post-Percutaneous Coronary Intervention (PCI) (see Percutaneous Coronary Intervention, [[Percutaneous Coronary Intervention]])

ST Elevation Myocardial Infarction (STEMI)

Pharmacology

Platelet P2Y12 Receptor Antagonist (see Platelet P2Y12 Receptor Antagonists, [[Platelet P2Y12 Receptor Antagonists]])

Metabolism

xxxx

Administration

xxxx

Dose Adjustment

Hepatic:

Renal:

Adverse Effects

Other Adverse Effects

xxx

xxx

xxx

References

xxxx